文献速递瓣膜外科

再次与初次微创二尖瓣手术的多中心注册研究比较

Redo Versus Primary Minimally Invasive Mitral Valve Surgery: Results From a Multicenter Registry.
PubMed 文献 · Ann Thorac Surg · 2026-09-16

本研究基于7个高容量中心2015至2024年的回顾性多中心注册数据,比较再次与初次微创二尖瓣手术的早期结局。共纳入1694例患者,其中158例(9.3%)有既往心脏手术史。再次手术组术前风险更高(EuroSCORE II 7.1% vs 1.3%,P < .001),但两组围术期死亡率和主要并发症无显著差异。

要点

  • 再次微创二尖瓣手术患者术前风险显著高于初次手术者。
  • 两组围术期死亡率和主要并发症无显著差异。
  • 再次手术组更常接受二尖瓣置换和合并三尖瓣手术。

核心结论

  • 再次微创二尖瓣手术患者术前风险更高,但围术期死亡率和主要并发症与初次手术相当。

研究设计与样本

  • 回顾性多中心注册研究,纳入7个高容量中心2015至2024年所有连续接受微创二尖瓣手术的患者,共1694例,其中158例(9.3%)有至少一次经正中胸骨切口的既往心脏手术史。

主要发现

  • 再次手术组EuroSCORE II显著更高(7.1% vs 1.3%,P < .001),合并症负担更重。
  • 再次手术组更常接受二尖瓣置换和合并三尖瓣手术。
  • 术中并发症、术后结局和院内死亡率两组无显著差异。

关键数值与推荐

  • 主要终点为围术期死亡率,两组无显著差异。
  • 再次手术组EuroSCORE II为7.1%,初次手术组为1.3%(P < .001)。

临床怎么用

  • 对于有既往正中胸骨切口心脏手术史的患者,微创二尖瓣手术可作为再次手术的可行策略,但需注意其术前风险更高。

局限性

  • 回顾性研究设计。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Redo mitral valve (MV) surgery is associated with increased perioperative risk, mainly related to repeat median sternotomy. Minimally invasive mitral valve surgery (MIMVS) has emerged as an alternative strategy, with excellent results reported in primary procedures; however, its adoption in redo setting remains limited. This study aimed to compare early outcomes of redo vs primary MIMVS in a large multicenter registry. METHODS: All consecutive patients undergoing MIMVS between 2015 and 2024 at 7 high-volume centers were retrospectively analyzed. Patients were divided in 2 groups: non-redo patients and patients with at least 1 previous cardiac surgery procedure through median sternotomy. The primary endpoint was perioperative mortality. RESULTS: Ultimately, 1694 patients were included, 158 (9.3%) had received previous cardiac surgery. Patients undergoing redo surgery presented a significantly higher preoperative risk profile, with higher EuroSCORE II (7.1% vs 1.3%, P < .001) and a greater burden of comorbidities. They were more likely to undergo MV replacement and concomitant tricuspid valve surgery. No significant differences were observed in intraoperative complications. Postoperative outcomes and in-hospital mortality were comparable between groups. CONCLUSIONS: Patients undergoing redo surgery arrive with a significantly higher risk profile when compared with patients undergoing primary MV surgery. Despite this, our analysis on patients undergoing MIMVS shows no differences in terms of perioperative mortality and major complications between groups.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Lodo V, Barbero C, Italiano E, et al. Redo Versus Primary Minimally Invasive Mitral Valve Surgery: Results From a Multicenter Registry. Ann Thorac Surg. 2026. PMID: 42749035. doi:10.1016/j.athoracsur.2026.09.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。